Glugacon-like peptide-2: Broad receptor expression, limited therapeutic effect on intestinal inflammation and novel role in liver regeneration
These include obesity, heart disease, kidney disease, heart failure, metabolic dysfunctionassociated steatotic liver disease, and obstructive sleep apnea, says Absalon D
While PAP may be beneficial in a subset of patients with OSA, emerging preclinical and clinical data suggest it may potentially cause harm in others [27], particularly at higher pressures [28], though this requires rigorous validation in future studies
For someone with significant insulin resistance, the same workaround could backfire
Most current discussion comes from small observational studies, conference reports, case experience, and biologic plausibility
"Good Morning America" spoke with two experts who shared the latest on these drugs and pregnancy